Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study-Reference-Cited by-同舟云学术

Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study

Published:2016-11 Issue: Volume:81 Page:212-222
ISSN:0273-2300
Container-title:Regulatory Toxicology and Pharmacology
language:en
Short-container-title:Regulatory Toxicology and Pharmacology

Author:

Chouinard Luc,Felx Melanie,Mellal Nacera,Varela Aurora,Mann Peter,Jolette Jacquelin,Samadfam Rana,Smith Susan Y.,Locher Kathrin,Buntich Sabina,Ominsky Michael S.,Pyrah Ian,Boyce Rogely Waite

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference50 articles.

1. WNT signalling pathways as therapeutic targets in cancer;Anastas;Nat. Rev. Cancer,2013

2. The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years;Andrews;J. Bone Min. Res.,2012

3. Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples;Bailer;Biometrics,1988

4. Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives;Baron;J. Clin. Endocrinol. Metab.,2012

5. WNT signaling in bone homeostasis and disease: from human mutations to treatments;Baron;Nat. Med.,2013

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Romosozumab versus parathyroid hormone receptor agonists: which osteoanabolic to choose and when?;European Journal of Endocrinology;2024-06-28

2. A practical approach for anabolic treatment of bone fragility with romosozumab;Journal of Endocrinological Investigation;2024-05-24

3. The co-receptor Tspan12 directly captures Norrin to promote ligand-specific β-catenin signaling;2024-04-22

4. The co-receptor Tspan12 directly captures Norrin to promote ligand-specific β-catenin signaling;2024-04-22

5. The co-receptor Tspan12 directly captures Norrin to promote ligand-specific β-catenin signaling;2024-02-03